AnlongMed Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
52
- Portfolio
-
33
- Exits
-
14
AnlongMed General Information
Company Description
Founded in 2019, AnlongMed is a venture capital fund based in Beijing, China. The firm focuses on early-stage and growth stages life science and healthcare sectors.
Business Details
Website
anlongmed.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 5th Floor, Building 2
- Number 10 Anxiang Street
- Beijing
- China
AnlongMed Investments (52)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| CorreGene | 02-Nov-2021 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Artivila Therapeutics | 31-Mar-2021 | Drug Discovery | Generating Revenue | |||
| Yuanqi Pharmaceutical | 26-Jan-2021 | Drug Discovery | Generating Revenue | |||
| Skynor | 20-Jan-2021 | Surgical Devices | Generating Revenue | |||
| AnlongBio | 06-Jan-2021 | Drug Discovery | Generating Revenue | |||
| Kurumi | 02-Sep-2020 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Amador Bioscience | 02-Jul-2020 | BPO/Outsource Services | Generating Revenue | |||
| Sophonix | 23-Jun-2020 | Diagnostic Equipment | Generating Revenue | |||
| Curegen Pharmacuticals | 11-Jun-2020 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| ArtechMed | 12-May-2020 | Early Stage VC | Surgical Devices | Generating Revenue |
AnlongMed Exits (14)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Amador Bioscience | 20-May-2024 | Secondary Transaction - Private | |
| Laekna Therapeutics | 16-Jun-2023 | ||
| Sonmol | 25-Nov-2022 | ||
| Vishuo Thailand | 01-Sep-2022 | ||
| Connect Biopharmaceuticals | 19-Mar-2021 | ||
| ToCell | 08-Mar-2020 | ||
| NovaBridge Biosciences | 16-Jan-2020 | ||
| GKHT Medical Technology | 31-Jul-2019 | ||
| Hanyu Medical | 02-Jul-2019 | Secondary Transaction - Private | |
| NetVation | 31-Dec-2018 | Merger/Acquisition |
AnlongMed Investments by Industry, Year, and Region
AnlongMed FAQs
-
What is AnlongMed?
Founded in 2019, AnlongMed is a venture capital fund based in Beijing, China.
-
When was AnlongMed founded?
AnlongMed was founded in 2019.
-
Where is AnlongMed headquartered?
AnlongMed is headquartered in Beijing, China.
-
What is AnlongMed's total asset value?
AnlongMed has around in total assets under management.
-
How many investments has AnlongMed made?
AnlongMed has made 52 investments.
-
What has AnlongMed invested in?
AnlongMed has made numerous investments in companies like CorreGene, Artivila Therapeutics, and Yuanqi Pharmaceutical within the Biotechnology and Drug Discovery industries.
-
What has AnlongMed invested in recently?
AnlongMed's latest investment was on 02-Nov-2021 in CorreGene, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process